Predictions
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€78.68
28.10.22
28.10.22
-
28.10.23
28.10.23
-7.17%
18.05.23
18.05.23
Risky Investment
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€301.55
28.10.22
28.10.22
-
28.10.23
28.10.23
-10.79%
01.01.23
01.01.23
Risky Investment
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€301.55
28.10.22
28.10.22
-
28.10.23
28.10.23
-10.79%
01.01.23
01.01.23
Risky Investment
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€301.55
28.10.22
28.10.22
-
28.10.23
28.10.23
-10.79%
01.01.23
01.01.23
Risky Investment
Twitter Inc.
Start price
Target price
Perf. (%)
€53.94
28.10.22
28.10.22
€160.00
28.10.23
28.10.23
-
29.10.22
29.10.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Orpea Nom.
Start price
Target price
Perf. (%)
€7.95
28.10.22
28.10.22
-
28.10.23
28.10.23
-16.20%
29.10.22
29.10.22
Could be very worthwhile Investment >20% year
Apple Inc.
Start price
Target price
Perf. (%)
€147.06
28.10.22
28.10.22
-
28.10.23
28.10.23
-2.41%
03.11.22
03.11.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
Apple Inc.
Start price
Target price
Perf. (%)
€147.06
28.10.22
28.10.22
-
28.10.23
28.10.23
-2.41%
03.11.22
03.11.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
Apple Inc.
Start price
Target price
Perf. (%)
€147.06
28.10.22
28.10.22
-
28.10.23
28.10.23
-2.41%
03.11.22
03.11.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
Apple Inc.
Start price
Target price
Perf. (%)
€147.06
28.10.22
28.10.22
-
28.10.23
28.10.23
-2.41%
03.11.22
03.11.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
Baker Hughes A GE Co.
Start price
Target price
Perf. (%)
€27.00
27.10.22
27.10.22
€35.00
31.05.24
31.05.24
0.65%
21.12.22
21.12.22
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€6.02
27.10.22
27.10.22
-
27.10.23
27.10.23
-42.03%
28.10.23
28.10.23
Could be worthwhile Investment >10% per year
Deutsche Bank AG
Start price
Target price
Perf. (%)
€9.67
27.10.22
27.10.22
€15.00
27.10.23
27.10.23
0.98%
02.11.22
02.11.22
Could be worthwhile Investment >10% per year
Deutsche Bank AG
Start price
Target price
Perf. (%)
€9.67
27.10.22
27.10.22
€15.00
27.10.23
27.10.23
0.98%
02.11.22
02.11.22
Could be worthwhile Investment >10% per year
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€105.26
27.10.22
27.10.22
€75.00
27.10.23
27.10.23
-5.09%
29.10.22
29.10.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€105.26
27.10.22
27.10.22
€75.00
27.10.23
27.10.23
-5.09%
29.10.22
29.10.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€105.26
27.10.22
27.10.22
€75.00
27.10.23
27.10.23
-5.09%
29.10.22
29.10.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
Rocket Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€17.96
26.10.22
26.10.22
€28.00
31.12.24
31.12.24
15.29%
08.06.24
08.06.24
Could be very worthwhile Investment >20% year
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€20.67
26.10.22
26.10.22
€35.00
31.12.24
31.12.24
-41.33%
21.12.22
21.12.22
Could be very worthwhile Investment >20% year